Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990558 · ClinicalTrials.gov registry record
Recovery of Consciousness Following Intracerebral Hemorrhage
A clinical trial of Intracerebral Hemorrhage, sponsored by Columbia University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT03990558: Recruiting study of Intracerebral Hemorrhage, sponsored by Columbia University.
NCT03990558 is a study of Intracerebral Hemorrhage that is actively recruiting participants, run by Columbia University. The registered enrollment target is 150 participants, below the 1,101-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03990558, a study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives of the RECONFIG clinical study are to : 1. To identify the time to the first diagnosis of cognitive motor dissociation (CMD) in intracerebral hemorrhage (ICH) patients and to investigate whether these patients will clinically follow commands earlier after the hemorrhage. 2. To determine whether CMD independently predicts long term functional outcomes (6-month mRS scores) in ICH patients, and is associated with long term cognitive and quality of life outcomes. 3. To determine the EEG response to verbal commands of the motor imagery paradigm between patients with and without sensory aphasia. The overall goal is to determine predictors and the trajectory of neurological recovery.
Primary Outcome
To investigate whether patients will clinically follow commands earlier after the hemorrhage.
Conditions Studied
Study Locations (2)
Florida
- University of Miami and Jackson Health System (UM/JHS) - Miami
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-06-15 |
| Est. Completion | 2026-03-31 |
What NCT03990558 shows while recruiting
NCT03990558 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,101-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.
NCT03990558 reports a single indexed study location in Florida, New York.
Frequently Asked Questions
What is clinical trial NCT03990558 about?
NCT03990558 is a clinical study titled "Recovery of Consciousness Following Intracerebral Hemorrhage". The objectives of the RECONFIG clinical study are to : 1. To identify the time to the first diagnosis of cognitive motor dissociation (CMD) in intracerebral hemorrhage (ICH) patients and to investigate whether these patients will clinically follow commands earlier after the hemorrhage. 2. To determ...
What is the current status of trial NCT03990558?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-06-15. Estimated completion is 2026-03-31.
What conditions does trial NCT03990558 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
Who is sponsoring clinical trial NCT03990558?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990558 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03990558's enrollment target sits among peer trials
150 19th of 31 higher than 13 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
ROSE-Longitudinal Assessment With Neuroimaging
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI